Are Peptides Legal in the US? State-by-State Guide

Key Takeaways

Peptides are legal in the US when obtained through a licensed provider with a valid prescription and filled at a licensed pharmacy
The FDA placed 19 peptides on the Category 2 list in 2023–2024, but HHS announced in February 2026 that approximately 14 would return to Category 1 — formal reclassification is pending
State laws add another layer — compounding pharmacy licensing, telehealth prescribing rules, and scope of practice vary significantly
“Research use only” peptides sold online exist in a legal grey area and are not legal for human use

Federal Peptide Regulation: The Big Picture
FDA Category System Explained
The 19 Category 2 Peptides
Which Peptides Are Legal to Compound Right Now?
State-by-State Regulatory Overview
The Grey Market: Research Peptides
2026 Reclassification: What’s Changing?
How to Get Peptides Legally
Frequently Asked Questions
Sources

Federal Peptide Regulation: The Big Picture

Peptide legality in the United States isn’t a simple yes-or-no question. It depends on the specific peptide, how it’s manufactured, who’s prescribing it, and what state you’re in.

At the federal level, peptide therapy is governed primarily by three frameworks:

The Federal Food, Drug, and Cosmetic Act (FD&C Act) — the backbone of drug regulation. Any substance intended to diagnose, treat, cure, or prevent disease is a drug under this law, regardless of what the label says [1].

Section 503A — allows traditional compounding pharmacies to prepare customized medications (including certain peptides) based on individual prescriptions, using approved bulk drug substances.

Section 503B — governs outsourcing facilities that can compound larger batches without individual prescriptions, but under stricter FDA oversight similar to drug manufacturers.

The practical result: FDA-approved peptides like semaglutide and sermorelin are legal with a prescription, just like any other prescription drug. Compounded peptides are legal when prepared by a licensed pharmacy from approved ingredients, pursuant to a valid prescription. Everything else falls into grey or outright illegal territory.

For a broader look at peptide legality beyond the US context, see our pillar guide on whether peptides are legal.

FDA Category System Explained

In 2024, the FDA formalized a category system for bulk drug substances eligible for compounding under Section 503A:

Category 1: Substances eligible for compounding. These have been evaluated and found to present no significant safety concerns when compounded appropriately. 503A pharmacies can compound these with a valid prescription [2].

Category 2: Substances identified as presenting potential safety risks. These are not currently eligible for routine compounding. The FDA’s concerns typically involve immunogenicity, aggregation risk, sterility challenges, or insufficient human safety data [3].

Category 3: Substances with insufficient information for evaluation. These are in regulatory limbo — not approved, not banned, just unresolved.

This category system is specific to compounding. It does not affect FDA-approved peptide drugs, which go through a completely separate approval pathway.

The 19 Category 2 Peptides

In 2023–2024, the FDA placed 19 peptides in Category 2. On February 27, 2026, HHS announced that approximately 14 of these would return to Category 1, though the formal reclassification has not yet been published [3]. Until formal FDA action, these peptides technically remain restricted:

Peptide	Common Use
BPC-157	Gut healing, tissue repair
CJC-1295	Growth hormone release
Ipamorelin acetate	Growth hormone release
GHK-Cu (injectable)	Anti-aging, wound healing
MOTS-C	Metabolic regulation
AOD-9604	Fat metabolism
Thymosin beta-4 fragment (TB-500)	Tissue repair
Thymosin alpha-1	Immune modulation
GHRP-2	Growth hormone release
GHRP-6	Growth hormone release
Melanotan II	Skin pigmentation
LL-37	Antimicrobial
DSIP (Emideltide)	Sleep regulation
Epitalon	Anti-aging
Kisspeptin-10	Reproductive hormones
KPV	Anti-inflammatory
PEG-MGF	Muscle growth
Semax	Cognitive function
Selank acetate	Anxiety, cognition

Many of these were widely available through compounding pharmacies before the Category 2 designation. Patients who previously used BPC-157 or CJC-1295 + ipamorelin stacks through legitimate prescriptions found their access cut off almost overnight.

For the full backstory on how this happened, see our guide on the FDA peptide reclassification of 2026.

Which Peptides Are Legal to Compound Right Now?

Despite the restrictions on Category 2 peptides, several therapeutically useful peptides remain available through licensed compounding pharmacies:

Sermorelin — a 29-amino-acid growth hormone-releasing hormone analog. Previously FDA-approved (brand name Geref), it has a strong clinical track record and can be compounded with a prescription. See our guides on sermorelin benefits and sermorelin side effects.

NAD+ — a coenzyme with FDA Generally Recognized as Safe (GRAS) status. Used in longevity and metabolic health protocols.

Semaglutide — while brand-name versions (Ozempic, Wegovy) are FDA-approved, compounded semaglutide is also available through 503B pharmacies during ongoing drug shortage designations. See our peptides for weight loss guide.

PT-141 (Bremelanotide) — FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women.

Collagen peptides and oral peptide supplements — regulated as dietary supplements, not drugs. These don’t require prescriptions and are widely available. Our guide on peptide supplements covers what’s worth considering.

State-by-State Regulatory Overview

Federal law provides the floor, but states build on top of it. Here’s how key regulatory areas vary:

Compounding Pharmacy Licensing

Every state requires compounding pharmacies to hold a state license, but the specifics differ:

Stricter states (California, Massachusetts, New York, New Jersey) impose additional inspections, reporting requirements, and quality testing standards beyond federal minimums
Standard states (most states) follow federal 503A/503B frameworks without significant additions
States with reciprocity allow pharmacies licensed in other states to ship compounded medications in, while some states require a separate non-resident pharmacy license

Telehealth Prescribing Rules

This matters because many people access peptide therapy online through telehealth:

Full telehealth prescribing — states like Florida, Texas, Arizona, and Colorado allow licensed providers to prescribe medications (including peptides) via telehealth without an initial in-person visit
Modified requirements — some states require an initial in-person visit, then allow telehealth follow-ups
Restrictive states — a few states have narrower telehealth prescribing rules, particularly for controlled substances (though most peptides aren’t controlled)

For details on getting peptides through telehealth, see our guide on whether telehealth can prescribe peptides.

Scope of Practice

Who can prescribe peptides varies by state:

Full practice states (25+ states including Arizona, Colorado, Oregon, Montana, Washington) — nurse practitioners can prescribe independently without physician oversight
Reduced practice states — NPs need a collaborative agreement with a physician but can still prescribe
Restricted practice states (California, Texas, Georgia, Missouri) — NPs require physician supervision for prescribing

This affects access in practice. In states with broader scope of practice, more providers can offer peptide therapy, which typically means more availability and sometimes lower costs. Our peptide clinic finder can help locate providers in your state.

Notable State-Specific Rules

Florida — one of the most peptide-friendly states. Strong compounding pharmacy infrastructure, permissive telehealth laws, and a large community of integrative medicine providers.

California — stricter pharmacy board oversight. California’s Board of Pharmacy has additional requirements for sterile compounding that exceed federal minimums. Telehealth is allowed but with some additional documentation requirements.

Texas — permissive telehealth environment. The Texas Medical Board allows most prescribing via telehealth. However, NPs need a supervisory agreement with a physician.

New York — requires non-resident pharmacy licenses for out-of-state compounding pharmacies shipping into the state. Telehealth prescribing is permitted but the state has been slower to adopt compared to Sun Belt states.

Arizona — very open regulatory environment for both telehealth and compounding. Full NP practice authority. Popular base for online peptide therapy clinics.

States with Peptide-Specific Actions

No state has passed laws specifically targeting peptides as a drug class. However, some states have taken relevant actions:

Several states added specific research chemicals to their controlled substance schedules (though this has primarily affected SARMs and prohormones, not peptides)
State pharmacy boards have issued guidance letters about compounding restrictions that mirror FDA Category 2 designations
Some state attorneys general have pursued action against companies selling unregulated peptides with therapeutic claims

The Grey Market: Research Peptides

The biggest source of confusion around peptide legality is the online grey market. Hundreds of websites sell peptides labeled “for research use only” (RUO) directly to consumers without prescriptions.

Here’s the legal reality:

Selling research peptides is legal — when they’re actually sold for laboratory research and not marketed for human use.

Using research peptides on yourself is where it gets complicated. Simple possession isn’t typically a criminal offense (most peptides aren’t scheduled controlled substances). But the products themselves are illegal to market for human use, and the FDA has taken action against vendors who implicitly encourage human use by selling peptides alongside bacteriostatic water and syringes [4].

Quality is the real issue. Research peptides have no requirements for sterility, potency verification, or endotoxin testing. Independent analyses have found significant variability in actual peptide content, bacterial contamination, and mislabeling [5]. Our guide on grey market peptides vs prescription covers the risks in detail.

If you’re considering peptides, the research peptides vs prescription peptides comparison explains why the prescription route is worth the extra cost and effort.

2026 Reclassification: What’s Changing?

The regulatory picture has shifted significantly. On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. announced on the Joe Rogan Experience that approximately 14 of 19 restricted peptides would return to Category 1, restoring legal compounding access [6]. The formal FDA reclassification has not yet been published but is expected within weeks.

Before the announcement, the FDA had faced a lawsuit over its Category 2 designations. The Peptide Legal Fund argued that the agency added 17 peptides to Category 2 without proper committee review or transparency. That lawsuit resulted in a settlement requiring the FDA to follow proper review procedures [7].

What reclassification will mean once formalized:

Category 2 peptides moved to Category 1 could be compounded by licensed pharmacies with a valid prescription
They would still not be FDA-approved drugs — no formal clinical indication, no standardized dosing
Providers would still need to prescribe them, and pharmacies would still need to follow USP 797/795 standards
The “research peptide” grey market would remain illegal for human use

What it would not mean:

Peptides would not become over-the-counter products
No one would be able to legally self-prescribe
Manufacturing standards would not be loosened

We’re tracking this closely. The formal FDA publication is expected within weeks. See our FDA peptide reclassification 2026 guide for the latest updates.

How to Get Peptides Legally

Regardless of your state, the legal pathway to peptide therapy follows the same basic steps:

Consult a licensed provider — find a peptide doctor or use a telehealth peptide clinic for a medical evaluation
Get appropriate lab work — providers typically want baseline bloodwork before prescribing
Receive a prescription — your provider writes a prescription for the specific peptide and dosage
Fill at a licensed pharmacy — a 503A or 503B compounding pharmacy prepares your medication
Follow up with your provider — ongoing monitoring ensures safety and effectiveness

For a deeper look at how to start, see our guide on how to get peptides prescribed.

Frequently Asked Questions

Are peptides legal to buy online?▼

FDA-approved peptides and compounded peptides from licensed pharmacies can be legally ordered online with a valid prescription. “Research use only” peptides sold without prescriptions are not legal for human use, even though the websites selling them operate openly.

Can I get in trouble for buying research peptides?▼

Individual possession of research peptides is unlikely to result in criminal charges since most peptides aren’t scheduled substances. However, the products are unregulated, unverified, and not legal to market for human consumption. The legal and health risks aren’t worth it when legitimate peptide therapy options exist.

Which states are best for peptide therapy access?▼

States with permissive telehealth laws, full NP practice authority, and strong compounding pharmacy infrastructure offer the easiest access. Florida, Arizona, Texas, and Colorado are commonly cited. But telehealth has made location less relevant — you can often consult with an out-of-state provider licensed in your state. Check our guide to peptide therapy near me via telehealth.

Are peptides controlled substances?▼

Most peptides are not classified as controlled substances at either the federal or state level. This means they don’t carry the same legal restrictions as opioids, stimulants, or anabolic steroids. However, they are still regulated as drugs when intended for therapeutic use and require prescriptions.

Will peptides become over the counter?▼

This is unlikely in the near term. Even if Category 2 peptides are reclassified to Category 1, they would still require prescriptions and pharmacy dispensing. The FDA has shown no interest in making injectable peptides available without prescriptions. Oral peptide supplements like collagen are already available OTC, but those are a different category entirely.

Sources

Federal Food, Drug, and Cosmetic Act. 21 U.S.C. §301 et seq.
FDA. Bulk Drug Substances Used in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act. Updated 2025.
Elite NP. FDA Peptide Reclassification 2026: What It Means for Providers and Patients. Published March 2026. https://elitenp.com/fda-peptide-reclassification-2026/
Frier Levitt. Regulatory Status of Peptide Compounding in 2025. Published April 2025. https://www.frierlevitt.com/articles/regulatory-status-of-peptide-compounding-in-2025/
Renew Vitality. Research Peptides vs. Pharmacy-Compounded Peptides: What’s the Real Difference? Published August 2025.
Kennedy RFK Jr. appearance on The Joe Rogan Experience. March 2026.
SafeHG. FDA’s Overreach on Compounded Peptides: Legal Battles and How Clinics Can Push Back. Published February 2026. https://www.safehg.com/fdas-overreach-on-compounded-peptides/
LumaLex Law. Do You Need A License To Sell Peptides In 2025. Published November 2025. https://www.lumalexlaw.com/2025/11/26/do-you-need-a-license-to-sell-peptides/